ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2662

Temporal Artery Biopsy Lengths in Alberta: Which Surgical Subspecialty Achieves Optimal Biopsy Lengths?

Raymond Chu1, Caylea Foster 2, Mohsin Ali 3, Todd Chaba 1, Jason Soo 1, Alison Clifford 1, Jan Willem Cohen Tervaert 1 and Elaine Yacyshyn 1, 1University of Alberta, Edmonton, Canada, 2University of Calgary, Calgary, Canada, 3Harvard, Boston, MA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: biopsies and quality improvement, giant cell arteritis, Temporal arteritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Session Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III: Giant Cell Arteritis

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Temporal arteritis or giant cell arteritis (GCA) is a large vessel vasculitis that involves extracranial arteries. Diagnosis requires a combination of clinical manifestations including symptoms of (scalp tenderness, claudication, visual disturbances), in the context of elevated inflammatory markers, in patients > 50 years of age. The gold standard of diagnosis continues to be a temporal artery biopsy. There is varying evidence regarding an ideal biopsy length, although current guidelines recommend at least 1 cm, with some evidence suggesting longer biopsies being ideal. The purpose of our study is to investigate whether biopsies performed in the province of Alberta, Canada are meeting guideline recommendations and whether different surgical subspecialties affect results of biopsies.

Methods: A retrospective chart review was performed on patients who had undergone a TAB procedure in 22 sites between January 1st, 2008 to January 1st, 2018. Data extracted included location of biopsy, post-fixation length, final pathological diagnoses and surgical subspecialty of individual performing biopsy. Predictors of positive pathology were modelled using logistic regression. Stata 14.1 (StataCorp) was used for data analysis.

Results: A total of 1203 biopsies were identified over the decade. Of these biopsies, we were able to identify the surgical specialist who performed the biopsy of 1003 biopsies. General surgery performed 428 (70 positive [16.36%]) positive biopsies with median length of 1 cm (QR, 0.7 – 1.5), Ophthalmology performed 393 (100 positive [25.45%]) biopsies with median length of 1.6 cm (QR, 1.2 – 2.1), Plastic Surgery  performed 162 (28 positive [17.28%]) biopsies with median length of 1.2 cm (QR, 0.8 – 1.7), Otolaryngology performed nine (one positive [11.11%]) biopsies with median length of 1.3 cm (QR, 0.3 – 1.5), Vascular Surgery performed eight (one positive [12.50%]) biopsies with median length of 3 cm (QR, 1.85 – 3.35), Family Medicine surgical assistants performed two (zero positive [0%]) biopsies with median length of 0.825 cm (QR, 0.65 – 1) and Neurosurgery performed one biopsy at 0.8 cm, which was negative for GCA. Univariate analysis noted ophthalmology as the only surgical subspecialty that was associated with positive GCA diagnosis with OR 1.74, 95% CI, 1.24 – 2.46; p = 0.001. We found that of the 22 sites who performed at least 31 biopsies, median lengths ranged between 0.8 cm to 2.2 cm.

Conclusion: This analysis evaluated the various surgical specialties who complete temporal artery biopsies. The surgical specialty with the highest yield of positive temporal artery biopsies was Ophthalmology, who perform the longest biopsies amongst surgical subspecialties and has the highest positive yield for a GCA diagnosis. Our study also indicates there are institutions in the province of Alberta who consistently do not meet the one cm biopsy length recommendations. This baseline data will inform further practice management for optimal biopsy lengths.


Disclosure: R. Chu, None; C. Foster, None; M. Ali, None; T. Chaba, None; J. Soo, None; A. Clifford, None; J. Cohen Tervaert, None; E. Yacyshyn, None.

To cite this abstract in AMA style:

Chu R, Foster C, Ali M, Chaba T, Soo J, Clifford A, Cohen Tervaert J, Yacyshyn E. Temporal Artery Biopsy Lengths in Alberta: Which Surgical Subspecialty Achieves Optimal Biopsy Lengths? [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/temporal-artery-biopsy-lengths-in-alberta-which-surgical-subspecialty-achieves-optimal-biopsy-lengths/. Accessed March 21, 2023.
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/temporal-artery-biopsy-lengths-in-alberta-which-surgical-subspecialty-achieves-optimal-biopsy-lengths/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences